These perturbations, which are amplified by their presence throughout the mucosa in the Muc2 mouse completely devoid of the mucus barrier, may identify changes in biochemistry and molecular pathways that drive higher probability of tumor development but which are only subtly and focally altered in the long-term development of common sporadic colon cancer. The gene discussed is MUC2; the disease is malignant colon neoplasm.